Literature DB >> 12559523

Influence of haemoglobin concentration and peripheral muscle pO2 on tumour oxygenation in advanced head and neck tumours.

Bernardino Clavo1, Juan L Pérez, Laura López, Gerardo Suárez, Marta Lloret, Jesús Morera, David Macías, José C Martínez, Maite Santana, María A Hernández, Francisco Robaina, Martina Günderoth.   

Abstract

Haemoglobin concentrations and tumour-pO(2) were evaluated pre-therapy in 30 patients with head and neck cancers. Anterior tibialis muscle-pO(2) was additionally measured in 16 of these patients. Tumour-pO(2) was lower in the most anaemic patients (P=0.032) and correlated with muscle-pO(2) (r=0.809, P<0.001). These results suggest that haemoglobin concentration influences tumour-oxygenation.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12559523     DOI： 10.1016/s0167-8140(02)00391-2

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  8 in total

1.  Erythropoietin in cancer treatment: considerations about Henke's article.

Authors:  Alberto Biete Sola; Felipe A Calvo Manuel; Bernardino Clavo Varas; Cristina Fernández Pérez; Carmen Porto Vázquez; Alejandro de la Torre Tomás; Almudena Zapatero Laborda
Journal:  Clin Transl Oncol       Date:  2005-09       Impact factor: 3.405

2.  Predictive value of hypoxia in advanced head and neck cancer after treatment with hyperfractionated radio-chemotherapy and hypoxia modification.

Authors:  B Clavo; F Robaina; D Fiuza; A Ruiz; M Lloret; D Rey-Baltar; P Llontop; A Riveros; J Rivero; F Castañeda; S Quintero; N Santana-Rodríguez
Journal:  Clin Transl Oncol       Date:  2016-08-15       Impact factor: 3.405

3.  Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression.

Authors:  Pedro C Lara; Marta Lloret; Bernardino Clavo; Rosa M Apolinario; Luis Alberto Henríquez-Hernández; Elisa Bordón; Fausto Fontes; Agustín Rey
Journal:  Radiat Oncol       Date:  2009-08-06       Impact factor: 3.481

4.  Plasminogen activator inhibitor-1 (PAI-1) expression in relation to hypoxia and oncoproteins in clinical cervical tumors.

Authors:  P C Lara; M Lloret; A Valenciano; B Clavo; B Pinar; A Rey; L A Henríquez-Hernández
Journal:  Strahlenther Onkol       Date:  2012-11-01       Impact factor: 3.621

5.  The HYP-RT hypoxic tumour radiotherapy algorithm and accelerated repopulation dose per fraction study.

Authors:  W M Harriss-Phillips; E Bezak; E Yeoh
Journal:  Comput Math Methods Med       Date:  2012-06-19       Impact factor: 2.238

6.  Adjuvant Ozonetherapy in Advanced Head and Neck Tumors: A Comparative Study.

Authors:  Bernardino Clavo; Ana Ruiz; Marta Lloret; Laura López; Gerardo Suárez; David Macías; Victor Rodríguez; Maria A Hernández; Roberto Martín-Oliva; Santiago Quintero; José M Cuyás; Francisco Robaina
Journal:  Evid Based Complement Alternat Med       Date:  2004-10-16       Impact factor: 2.629

7.  Chronic hyperglycemia is an adverse prognostic factor for locoregional recurrence-free survival in small cell lung cancer patients treated with radical radiotherapy.

Authors:  Moonkyoo Kong; Yu Jin Lim
Journal:  Thorac Cancer       Date:  2022-08-04       Impact factor: 3.223

8.  Ozone Therapy for Tumor Oxygenation: a Pilot Study.

Authors:  Bernardino Clavo; Juan L. Pérez; Laura López; Gerardo Suárez; Marta Lloret; Victor Rodríguez; David Macías; Maite Santana; María A. Hernández; Roberto Martín-Oliva; Francisco Robaina
Journal:  Evid Based Complement Alternat Med       Date:  2004-06-01       Impact factor: 2.629
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.